Kenneth Baillie
CEO, Multiscale Labs
Kenneth Baillie FRSE FMedSci is a consultant in critical care medicine, and an accomplished computational biologist. He leads the largest consented research study in the history of his specialty worldwide (GenOMICC), leads the UK's flagship academic study of functional genomics in human tissue (UKRI FGx MMC), and co-led the largest study of hospitalised Covid-19 patients in the world (ISARIC4C).
Events Kenneth Baillie has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026